mTouche Technology Berhad, together with its subsidiaries, provides mobile messaging technology services in Malaysia and internationally.
It is also engaged in the research and development of technologies in the field of information technology and telecommunications; distribution and sale, installation, and service of telecommunications and multimedia systems and related activities. The company's mTouche Intelligent Short Messaging Platform enables mobile network operators and service providers to offer cross network connectivity to applications and short message receiving, storing, and forwarding services.
MTOUCHE’s established client:
mTouche Technology Bhd will market and distribute medical equipment for Malaysia and Southeast Asian markets. mTouche said its wholly-owned mTouche International Sdn Bhd, had signed a supply agreement with Network Global Solutions Pty Ltd on the venture.
Tang Boon Koon, executive director of mTouche said the world was experiencing a scarcity of medical equipment such as test kits, ventilators and protective gears whereas Darren Whittaker, managing director of NGS said: "We believe this collaboration with mTouche is a perfect match for our strategic direction and we are excited by the potential of this partnership.”
He added that the companies were focusing all their resources in bringing the much needed test kits, masks and other critical supplies to the frontlines as soon as possible.
INVESTORS are drawn to technology stocks because of their bigger growth potential in an era of increasing digitisation, automation and artificial intelligence.
Dividends tend to be secondary as, historically, technology companies are expected to reinvest their earnings into growth initiatives to drive further expansion.
A closer look at Bursa Malaysia reveals that there are a handful of tech or tech-related stocks that offer higher yields, particularly now that fixed deposit rates are measly following the central bank’s paring of the overnight policy rate to a 10-year low of 2%.
https://www.klsescreener.com/v2/news/view/698273
2. MTOUCHE TAPPING INTO COVID19 TEST KIT
Last 15 April 2020, its wholly-owned subsidiary mTouche International Sdn Bhd (MISB) signed a supply agreement with Network Global Solutions Pty Ltd (NGS) to distribute novel coronavirus (2019-nCoV) detection, diagnostic and rapid test kits besides medical products across Southeast Asia.
The 2019-nCoV is now officially known as the Covid-19 virus.
NGS will sell the products as required by MISB and MISB agrees to purchase for the price subject to the terms and conditions of this agreement, for its day-to-day sales and distributing activities during the terms of this agreement.
3. TECHNICAL VIEW
The support and resistance of MTOUCHE are 0.60 & 0.085 respectively. MACD line is above the centreline indicating some degree of strength in the price movement.
Based on the technical’s view, MTOUCHE trading at its immediate support at 6.5sen and 6 sen. There is sudden volume activity at 6.5sen which shows that collection is occur at that price
CONCLUSION
Considering all the above, I opine that current price for MTOUCHE is attractive due to below:
1. MTOUCHE VENTURING TO PPE BUSINESS
2. MTOUCHE TAPPING INTO COVID19 TEST KIT
LET’S SEE HOW THE SHARE PRICE MOVEMENT IN THE NEAR FUTURE FORBEARING ANY GOOD CORPORATE NEWS.
Disclaimer : The above opinion is never intended to be a BUY CALL whatsoever. I am sharing my observations ONLY based on fundamental; past history; current trading pattern; charts etc. Please make your own informed decision before buying this share or whatever share for that matter.
BURSAMASTER
Chart | Stock Name | Last | Change | Volume |
---|
Created by BURSAMASTER | Sep 22, 2023
Created by BURSAMASTER | Aug 20, 2023
DISCLAIMER: This post serves as an educational analysis and is never meant/ intended to be a buy/sell call or recomendation, whatsoever.
Investors / punters must always do their own due deligence bef
Created by BURSAMASTER | Dec 25, 2022
Created by BURSAMASTER | Oct 23, 2021
Created by BURSAMASTER | Dec 26, 2020
Read more about vaccine development. This is not like making Nasi Lemak. The fastest vaccine ever developed took 4 years! If the health experts read your comment, they will laugh at your naivety.
2020-07-13 14:20
https://www.thehindu.com/sci-tech/health/chinas-cansino-in-talks-for-covid-19-vaccine-phase-iii-trial-overseas/article32062792.ece
Phase 3 already. Full steam ahead! Coming to u sooner than u think
2020-07-13 17:37
greedy44444
Vaccine coming soon.... better buy construction stocks, the next theme play. End of glove stocks and medical stocks.
2020-07-12 12:17